期刊文献+

表观遗传修饰在糖尿病肾病发病机制中的作用研究进展 被引量:2

Progress of research on the role of epigenetic modification in pathogenesis of diabetic nephropathy
原文传递
导出
摘要 "代谢记忆"现象是导致糖尿病并发症发病率持续增高的重要原因,其分子机制的研究主要聚焦在表观遗传修饰。表观遗传修饰在糖尿病肾病的纤维化、炎症、氧化应激、糖代谢及脂代谢紊乱等发病机制中有重要的作用。本文就该机制做一综述,并为进一步的分子研究、诊断及治疗提供新思路。 “Metabolic memory”phenomenon is an important reason that leads to the rising incidence of diabetes complications.Efforts to understand molecular mechanisms of the metabolic memory have been focused on the epigenetic modification.The epigenetic modification plays an important role in the pathogenesis of diabetic nephropathy,including fibrosis,inflammation,oxidative stress,and disorders of glucose metabolism and lipid metabolism,which was reviewed in this article,in order to provide new ideas for further molecular research,diagnosis,and treatment.
出处 《中华肾病研究电子杂志》 2016年第4期177-181,共5页 Chinese Journal of Kidney Disease Investigation(Electronic Edition)
基金 973项目(2015CB553605) 国家自然科学基金(81473531,61471399,61001218) 解放军总医院科技创新苗圃基金(16KMM08),解放军总医院临床科研扶持基金(2016FC-TSYS-1043)
关键词 表观遗传修饰 糖尿病肾病 发病机制 Epigenetic modification Diabetic nephropathy Pathogeneses
  • 相关文献

参考文献1

二级参考文献47

  • 1Center for Disease Control and Prevention. National DiabetesFact Sheet. 2011. Available from: URL: http://www.cdc.gov/diabetes/pubs/factsheet11.htm.
  • 2International Diabetes Federation. IDF Diabetes Atlas. 6th ed.Available from: URL: http://www.idf.org/diabetesatlas/.
  • 3Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, HenryRR, Pratley R, Zinman B. Impaired fasting glucose and impairedglucose tolerance: implications for care. Diabetes Care 2007; 30:753-759 [PMID: 17327355 DOI: 10.2337/dc07-9920].
  • 4DeFronzo RA, Abdul-Ghani M. Assessment and treatment ofcardiovascular risk in prediabetes: impaired glucose tolerance andimpaired fasting glucose. Am J Cardiol 2011; 108: 3B-24B [PMID:21802577 DOI: 10.1016/j.amjcard.2011.03.013].
  • 5Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL,Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, CollinsVR, Hamman RF. Predictors of progression from impaired glucosetolerance to NIDDM: an analysis of six prospective studies. Diabetes1997; 46: 701-710 [PMID: 9075814 DOI: 10.2337/diab.46.4.701].
  • 6Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ,Rubin RR, Chasan-Taber L, Albright AL, Braun B. Exercise and type2 diabetes: the American College of Sports Medicine and the AmericanDiabetes Association: joint position statement. Diabetes Care 2010; 33:e147-e16.
  • 7[PMID: 21115758 DOI: 10.2337/dc10-9990]7 Wren JD, Garner HR. Data-mining analysis suggests an epigeneticpathogenesis for type 2 diabetes. J Biomed Biotechnol 2005; 2005:104-112 [PMID: 16046815 DOI: 10.1155/JBB.2005.104].
  • 8Gallou-Kabani C, Junien C. Nutritional epigenomics of metabolicsyndrome: new perspective against the epidemic. Diabetes 2005; 54:1899-1906 [PMID: 15983188 DOI: 10.2337/diabetes.54.7.1899].
  • 9Gallou-Kabani C, Vig-A, Junien C. Lifelong circadian andepigenetic drifts in metabolic syndrome. Epigenetics 2007; 2:137-146 [PMID: 17965598 DOI: 10.4161/epi.2.3.4897].
  • 10Jirtle RL, Skinner MK. Environmental epigenomics and diseasesusceptibility. Nat Rev Genet 2007; 8: 253-262 [PMID: 17363974DOI: 10.1038/nrg2045].

共引文献5

同被引文献21

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部